https://european-biotechnology.net/wp-content/uploads/2025/12/FDA-White-Oak-Building-01.jpg220420Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-19 10:41:062025-12-19 10:41:06Egetis Therapeutics AB submits rolling NDA for tiratricol
https://european-biotechnology.net/wp-content/uploads/2025/12/Thanos-Halazonetis-scaled-e1766052380320-1030x581-1.png5811030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-18 10:09:392025-12-18 10:09:39FoRx raises US$50m in Series A to advance PARG inhibitor
https://european-biotechnology.net/wp-content/uploads/2025/12/Sam-Possemiers-in-Lab_-Christophe-De-Muynck-2-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-18 08:54:212025-12-18 08:54:21Belgian microbiome player MRM Health initiates R&D partnership in cancer immunotherapy
https://european-biotechnology.net/wp-content/uploads/2025/12/49690783712_769ff8c691_k-e1765881176243-1030x580-1.jpg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-16 10:32:152025-12-16 10:32:15Sanofi facing tolebrutinib setback in MS
https://european-biotechnology.net/wp-content/uploads/2025/12/FIDA-1030x481-1.png4811030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-16 09:44:182025-12-16 09:44:18Eifo and Fsg back Fida Biosystems with €5m investment
https://european-biotechnology.net/wp-content/uploads/2025/12/2019_09_03_zealand.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-12-12 08:28:062025-12-12 08:28:06Zealand pays Chinese OTR US$30m upfront to expand obesity pipeline
